Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

4G6K

Crystal structure of the therapeutic antibody binding fragment of gevokizumab in its unbound state

Summary for 4G6K
Entry DOI10.2210/pdb4g6k/pdb
Related4G5Z 4G6J 4G6M
Descriptorheavy chain of gevokizumab antibody binding fragment, light chain of gevokizumab antibody binding fragment (3 entities in total)
Functional Keywordsimmunoglobulin fold, immune system, cytokine, interleukine-1beta
Biological sourcehomo Sapiens, Mus musculus (human, mouse)
More
Total number of polymer chains2
Total formula weight46791.32
Authors
Blech, M.,Hoerer, S. (deposition date: 2012-07-19, release date: 2012-12-19, Last modification date: 2023-09-13)
Primary citationBlech, M.,Peter, D.,Fischer, P.,Bauer, M.M.,Hafner, M.,Zeeb, M.,Nar, H.
One target-two different binding modes: Structural insights into gevokizumab and canakinumab interactions to interleukin-1beta
J.Mol.Biol., 425:94-111, 2013
Cited by
PubMed: 23041424
DOI: 10.1016/j.jmb.2012.09.021
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.9 Å)
Structure validation

218500

數據於2024-04-17公開中

PDB statisticsPDBj update infoContact PDBjnumon